Royce & Associates LP grew its holdings in Teleflex Incorporated (NYSE:TFX – Free Report) by 73.6% during the 3rd quarter, Holdings Channel reports. The firm owned 145,882 shares of the medical technology company’s stock after buying an additional 61,842 shares during the period. Royce & Associates LP’s holdings in Teleflex were worth $18,241,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Teleflex during the 2nd quarter worth approximately $688,537,000. Jupiter Topco LLC acquired a new position in shares of Teleflex during the 2nd quarter worth approximately $550,456,000. Janus Henderson Group PLC lifted its stake in Teleflex by 1.1% in the 1st quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company’s stock valued at $513,281,000 after buying an additional 45,199 shares in the last quarter. Irenic Capital Management LP purchased a new stake in Teleflex in the 1st quarter valued at approximately $104,061,000. Finally, Pzena Investment Management LLC purchased a new stake in Teleflex in the 2nd quarter valued at approximately $76,462,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
TFX has been the topic of a number of analyst reports. Royal Bank Of Canada increased their target price on Teleflex from $155.00 to $175.00 and gave the company an “outperform” rating in a report on Friday, November 6th. Mizuho set a $160.00 price target on Teleflex in a report on Friday, November 6th. Truist Financial upped their price objective on Teleflex from $142.00 to $167.00 and gave the company a “hold” rating in a research report on Monday, November 9th. Wall Street Zen raised Teleflex from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Finally, Wells Fargo & Company lifted their price objective on Teleflex from $138.00 to $167.00 and gave the stock an “equal weight” rating in a research report on Friday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $163.30.
Check Out Our Latest Stock Report on TFX
Teleflex Stock Performance
NYSE:TFX opened at $155.00 on Monday. The firm has a 50 day simple moving average of $133.59 and a 200-day simple moving average of $127.37. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.01 and a quick ratio of 1.59. The firm has a market cap of $6.15 billion, a PE ratio of 18.83, a P/E/G ratio of 1.04 and a beta of 0.85. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $156.75.
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The medical technology company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.73. Teleflex had a net margin of 13.51% and a return on equity of 10.57%. The business had revenue of $567.80 million for the quarter, compared to the consensus estimate of $565.52 million. During the same quarter in the prior year, the firm posted $3.67 earnings per share. The company’s quarterly revenue was up .1% compared to the same quarter last year. On average, equities analysts expect that Teleflex Incorporated will post 7.67 EPS for the current year.
Teleflex Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 31st. Shareholders of record on Monday, November 16th will be issued a $0.34 dividend. The ex-dividend date is Monday, November 16th. This represents a $1.36 annualized dividend and a yield of 0.9%. Teleflex’s payout ratio is 16.52%.
Teleflex Company Profile
Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.
Recommended Stories
- Five stocks we like better than Teleflex
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
